Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

FDG PET/CT Can Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy: Evidence From Meta-analysis and Systematic Review.

Rymer B, Curtis NJ, Siddiqui MR, Chand M.

Clin Nucl Med. 2016 May;41(5):371-5. doi: 10.1097/RLU.0000000000001166. Review.

PMID:
26914561
2.

New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.

Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH.

Clin Nucl Med. 2013 Jan;38(1):7-12. doi: 10.1097/RLU.0b013e3182639a58.

PMID:
23242038
3.

Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT.

Am J Clin Oncol. 2012 Aug;35(4):334-9. doi: 10.1097/COC.0b013e3182118d12.

PMID:
21422989
4.

18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis.

Li C, Lan X, Yuan H, Feng H, Xia X, Zhang Y.

Ann Nucl Med. 2014 Jun;28(5):436-46. doi: 10.1007/s12149-014-0837-6. Epub 2014 Mar 13.

PMID:
24623152
5.

Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.

Kim JW, Kim HC, Park JW, Park SC, Sohn DK, Choi HS, Kim DY, Chang HJ, Baek JY, Kim SY, Kim SK, Oh JH.

Int J Colorectal Dis. 2013 Sep;28(9):1217-24. doi: 10.1007/s00384-013-1657-1. Epub 2013 Feb 13.

PMID:
23404344
6.

Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.

Li QW, Zheng RL, Ling YH, Wang QX, Xiao WW, Zeng ZF, Fan W, Li LR, Gao YH.

Abdom Radiol (NY). 2016 Aug;41(8):1448-55. doi: 10.1007/s00261-016-0698-7.

PMID:
27116012
7.

The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.

Murcia Duréndez MJ, Frutos Esteban L, Luján J, Frutos MD, Valero G, Navarro Fernández JL, Mohamed Salem L, Ruiz Merino G, Claver Valderas MA.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):91-7. doi: 10.1007/s00259-012-2257-y. Epub 2012 Oct 19.

PMID:
23081822
8.

Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.

Maffione AM, Chondrogiannis S, Capirci C, Galeotti F, Fornasiero A, Crepaldi G, Grassetto G, Rampin L, Marzola MC, Rubello D.

Eur J Surg Oncol. 2014 Oct;40(10):1186-94. doi: 10.1016/j.ejso.2014.06.005. Epub 2014 Jul 2. Review.

PMID:
25060221
9.

The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.

Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.

Am J Clin Oncol. 2012 Aug;35(4):340-4. doi: 10.1097/COC.0b013e3182118e7d.

PMID:
21422901
10.

Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.

Fischer MA, Vrugt B, Alkadhi H, Hahnloser D, Hany TF, Veit-Haibach P.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1563-73. doi: 10.1007/s00259-014-2752-4. Epub 2014 Apr 24.

PMID:
24760269
11.

FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.

Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH.

BMC Med Imaging. 2017 Jan 5;17(1):1. doi: 10.1186/s12880-016-0171-7.

12.

Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?

Perez RO, Habr-Gama A, São Julião GP, Gama-Rodrigues J, Sousa AH Jr, Campos FG, Imperiale AR, Lynn PB, Proscurshim I, Nahas SC, Ono CR, Buchpiguel CA.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1159-65. doi: 10.1016/j.ijrobp.2012.01.096. Epub 2012 May 12.

PMID:
22580120
13.

Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93. Epub 2007 May 15.

PMID:
17503039
14.

Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.

Maffione AM, Ferretti A, Grassetto G, Bellan E, Capirci C, Chondrogiannis S, Gava M, Marzola MC, Rampin L, Bondesan C, Colletti PM, Rubello D.

Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):853-64. doi: 10.1007/s00259-013-2357-3. Epub 2013 Feb 16.

PMID:
23417501
15.

The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.

Sun W, Xu J, Hu W, Zhang Z, Shen W.

Colorectal Dis. 2013 May;15(5):e231-8. doi: 10.1111/codi.12165.

PMID:
23384167
16.

Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis.

Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D.

AJR Am J Roentgenol. 2015 Jun;204(6):1261-8. doi: 10.2214/AJR.14.13210. Review.

PMID:
26001237
17.

Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?

Fagundes TC, Mafra A, Silva RG, Castro ACG, Silva LC, Aguiar PT, Silva JA, P Junior E, Machado AM, Mamede M.

Rev Assoc Med Bras (1992). 2018 Feb;64(2):119-126. doi: 10.1590/1806-9282.64.02.119.

18.

The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1461-9. doi: 10.1016/j.ijrobp.2008.10.064. Epub 2009 May 4.

PMID:
19419820
19.

Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.

Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.

PMID:
22395978
20.

Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.

Petrillo A, Fusco R, Petrillo M, Granata V, Delrio P, Bianco F, Pecori B, Botti G, Tatangelo F, Caracò C, Aloj L, Avallone A, Lastoria S.

Oncotarget. 2017 Jan 31;8(5):8143-8153. doi: 10.18632/oncotarget.14106.

Supplemental Content

Support Center